Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Display Settings
النتائج لكل صفحة: 10
Sort By: Relevance
Filter
  • 1-10 ل  8,057 نتائج ل ""Cytokine Release Syndrome""

فلترة النتائج

Subject : cytokine release syndrome
إعادة تعيين خيارات الفبترة
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Identification of cytokine release syndrome and indicators of severity in retrospective databases among patients receiving immunotherapy.

Subjects: Cytokine Release Syndrome*/Cytokine Release Syndrome*/Cytokine Release Syndrome*/etiology ; Algorithms* ; Databases, Factual*

  • Source: Pharmacology research & perspectives [Pharmacol Res Perspect] 2024 Dec; Vol. 12 (6), pp. e70024.Publisher: John Wiley & Sons Ltd, British Pharmacological Society and American Society for Pharmacology and Experimental Therapeutics Country of Publication: United States

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

The degree of HLA matching determines the incidence of cytokine release syndrome and associated nonrelapse mortality in matched related and unrelated allogeneic stem cell transplantation with post-transplant cyclophosphamide.

Subjects: Cytokine Release Syndrome*/Cytokine Release Syndrome*/Cytokine Release Syndrome*/etiology ; Cytokine Release Syndrome*/Cytokine Release Syndrome*/Cytokine Release Syndrome*/mortality ; Cyclophosphamide*/Cyclophosphamide*/Cyclophosphamide*/therapeutic use

  • Source: Leukemia & lymphoma [Leuk Lymphoma] 2024 Sep; Vol. 65 (9), pp. 1270-1280. Date of Electronic Publication: 2024 May 06.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Evaluating drug interaction potential from cytokine release syndrome using a physiologically based pharmacokinetic model: A case study of teclistamab.

Subjects: Drug Interactions* ; Interleukin-6*/Interleukin-6*/Interleukin-6*/blood ; Cytokine Release Syndrome*/Cytokine Release Syndrome*/Cytokine Release Syndrome*/drug therapy

  • Source: CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2024 Jul; Vol. 13 (7), pp. 1117-1129. Date of Electronic Publication: 2024 Jun 03.Publisher: Wiley Country of Publication: United States NLM ID: 101580011 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Editorial & Opinion

Is PBPK useful to inform product label on managing clinically significant drug interactions mediated by cytokine release syndrome?

  • Authors : Zhang X; Quantitative Clinical Pharmacology, Daiichi Sankyo, Inc., Basking Ridge, New Jersey, USA.; Zhao P

Subjects: Drug Interactions* ; Cytokine Release Syndrome*/Cytokine Release Syndrome*/Cytokine Release Syndrome*/drug therapy; Humans

  • Source: CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2024 Jul; Vol. 13 (7), pp. 1083-1087. Date of Electronic Publication: 2024 Jun 12.Publisher: Wiley Country of Publication: United States NLM ID: 101580011 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Treatment of cytokine release syndrome-induced vascular endothelial injury using mesenchymal stem cells.

  • Authors : Wang Y; Department of Laboratory Medicine, The First Affiliated Hospital of Yangtze University, Jingzhou, China.; Health Science Center, Yangtze University, Jingzhou, China.

Subjects: Mesenchymal Stem Cells*/Mesenchymal Stem Cells*/Mesenchymal Stem Cells*/metabolism ; Mesenchymal Stem Cell Transplantation* ; Cytokine Release Syndrome*/Cytokine Release Syndrome*/Cytokine Release Syndrome*/etiology

  • Source: Molecular and cellular biochemistry [Mol Cell Biochem] 2024 May; Vol. 479 (5), pp. 1149-1164. Date of Electronic Publication: 2023 Jul 01.Publisher: Springer Country of Publication: Netherlands NLM ID: 0364456 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

The role of C-reactive protein and ferritin in the diagnosis of HLH, adult-onset still's disease, and COVID-19 cytokine storm.

  • Authors : Goubran M; Department of Medicine, University of British Columbia, Vancouver, BC, Canada.; Spaner C

Subjects: Still's Disease, Adult-Onset*/Still's Disease, Adult-Onset*/Still's Disease, Adult-Onset*/blood ; Still's Disease, Adult-Onset*/Still's Disease, Adult-Onset*/Still's Disease, Adult-Onset*/diagnosis ; Ferritins*/Ferritins*/Ferritins*/blood

  • Source: Scientific reports [Sci Rep] 2024 Dec 28; Vol. 14 (1), pp. 31306. Date of Electronic Publication: 2024 Dec 28.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Aged Garlic Extract (AGE) and Its Constituent S-Allyl-Cysteine (SAC) Inhibit the Expression of Pro-Inflammatory Genes Induced in Bronchial Epithelial IB3-1 Cells by Exposure to the SARS-CoV-2 Spike Protein and the BNT162b2 Vaccine.

  • Authors : Gasparello J; Department of Life Sciences and Biotechnology, Ferrara University, 44121 Ferrara, Italy.; Papi C

Subjects: Plant Extracts*/Plant Extracts*/Plant Extracts*/chemistry ; Plant Extracts*/Plant Extracts*/Plant Extracts*/pharmacology ; Plant Extracts*/Plant Extracts*/Plant Extracts*/therapeutic use

  • Source: Molecules (Basel, Switzerland) [Molecules] 2024 Dec 16; Vol. 29 (24). Date of Electronic Publication: 2024 Dec 16.Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-3049

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

SARS-CoV-2-induced cytokine storm drives prolonged testicular injury and functional impairment in mice that are mitigated by dexamethasone.

  • Authors : Giannakopoulos S; Department of Cell and Molecular Biology, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, Hawaii, United States of America.; Department of Tropical Medicine, Medical Microbiology and Pharmacology, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, Hawaii, United States of America.

Subjects: COVID-19*/COVID-19*/COVID-19*/complications ; COVID-19*/COVID-19*/COVID-19*/immunology ; Dexamethasone*/Dexamethasone*/Dexamethasone*/pharmacology

  • Source: PLoS pathogens [PLoS Pathog] 2025 Jan 07; Vol. 21 (1), pp. e1012804. Date of Electronic Publication: 2025 Jan 07 (Print Publication: 2025).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

A Novel Engineering Cell Therapy Platform Mimicking the Immune Thrombocytopenia-Derived Platelets to Inhibit Cytokine Storm in Hemophagocytic Lymphohistiocytosis.

  • Authors : Liu Z; Department of Hematology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, 210008, China.; Du Y

Subjects: Lymphohistiocytosis, Hemophagocytic*/Lymphohistiocytosis, Hemophagocytic*/Lymphohistiocytosis, Hemophagocytic*/immunology ; Lymphohistiocytosis, Hemophagocytic*/Lymphohistiocytosis, Hemophagocytic*/Lymphohistiocytosis, Hemophagocytic*/therapy ; Cytokine Release Syndrome*/Cytokine Release Syndrome*/Cytokine Release Syndrome*/immunology

  • Source: Advanced science (Weinheim, Baden-Wurttemberg, Germany) [Adv Sci (Weinh)] 2024 Dec; Vol. 11 (45), pp. e2404571. Date of Electronic Publication: 2024 Sep 11.Publisher: WILEY-VCH Country of Publication: Germany NLM ID: 101664569 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2198-3844

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Melatonin as an immunomodulator in CD19-targeting CAR-T cell therapy: managing cytokine release syndrome.

  • Authors : Zheng N; General Clinical Research Center, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, China.; Long Y

Subjects: Cytokine Release Syndrome*/Cytokine Release Syndrome*/Cytokine Release Syndrome*/therapy ; Immunotherapy, Adoptive*/Immunotherapy, Adoptive*/Immunotherapy, Adoptive*/adverse effects ; Melatonin*/Melatonin*/Melatonin*/pharmacology

  • Source: Journal of translational medicine [J Transl Med] 2024 Jan 14; Vol. 22 (1), pp. 58. Date of Electronic Publication: 2024 Jan 14.Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-5876

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
  • 1-10 ل  8,057 نتائج ل ""Cytokine Release Syndrome""